Interspecies homology of liver microsomal cytochrome P-450: A form of dog cytochrome P-450 (P-450-D1) crossreactive with antibodies to rat P-450-male

doi:10.1016/0006-2952(89)90032-4

Biochemical Pharmacology

Volume 38, Issue 2, 15 January 1989, Pages 235-240

https://doi.org/10.1016/0006-2952(89)90032-4 Get rights and content

Abstract

P-450-male is a male specific form of cytochrome P-450 in rat liver microsomes. Cytochrome P-450 crossreactive with anti-P-450-male antibodies was purified to an electrophoretical homogeneity from liver microsomes of male beagle dogs. The specific content of the purified cytochrome P-450 (P-450-D1) was 16.9 nmol/mg protein. The apparent monomeric molecular weight of P-450-D1 was 48,000, which was smaller than P-450-male (51,000). P-450-D1 showed similarities in spectral properties, N-terminal amino acid sequence, and catalytic activities with some limited exceptions: P-450-D1 did not catalyze 2α-hydroxylation of testosterone and progesterone and catalyzed 21-hydroxylation of progesterone. Based on these results, we propose that P-450-D1 is a form of cytochrome P-450 in the same gene subfamily as P-450-male.

References (28)

T. Kamataki et al.
Archs Biochem. Biophys.
(1983)
K-C. Cheng et al.
J. biol. Chem.
(1983)
M. Haniu et al.
Archs Biochem. Biophys.
(1984)
D.J. Waxman
J. biol. Chem.
(1984)
A.H. Nishikawa et al.
Analyt. Biochem.
(1975)
Y. Yasukochi et al.
J. biol. Chem.
(1976)
Y. Funae et al.
Biochim. biophys. Acta
(1985)
O.H. Lowry et al.
J. biol. Chem.
(1951)
T. Omura et al.
J. biol. Chem.
(1964)
W. Wray et al.
Analyt. Biochem.
(1981)

A. Aitio

Analyt. Biochem.

(1978)

H. Yoshioka et al.

J. biol. Chem.

(1987)

A.Y.H. Lu et al.

Pharmac. Rev.

(1980)

D.E. Ryan et al.

Xenobiotica

(1982)

Cited by (18)

Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 34 in human liver microsomes
1997, Archives of Biochemistry and Biophysics
Roles of human cytochrome P450 (P450 or CYP) 2C9, 2C19, and 3A4 in the oxidation of progesterone and testosterone were studied in recombinant P450 enzymes and in human liver microsomes.In vitroinhibition experiments showed that progesterone and its 17α- and 21-hydroxylated metabolites and 11-deoxycortisol suppressed the CYP2C19-dependentR-warfarin 7-hydroxylation activities, with progesterone being the most active. These steroid chemicals also inhibited CYP2C9-dependentS-warfarin 7-hydroxylation activities though lesser extents seen with those in CYP2C19 enzyme. Progesterone was found to be a competitive inhibitor of CYP2C19 and CYP2C9 in human liver microsomes. Recombinant CYP2C19 catalyzed progesterone to form 21-hydroxyprogesterone as a major product and 16α- and 17α-hydroxyprogesterone as minor products. CYP2C9 also had progesterone 21-hydroxylation activities, although the activities were lower than those catalyzed by CYP2C19.V_max/K_mratios for the progesterone 21-hydroxylation activity of CYP2C19 were determined to be 13- and 32-fold higher than those of CYP2C9 and 3A4, respectively. CYP3A4 oxidized progesterone to form 16α-, 6β-, and 2β-hydroxyprogesterone as major products and 21-hydroxyprogesterone as a minor product, but did not produce detectable levels of 17α-hydroxyprogesterone. Immunoinhibition experiments suggested that anti-CYP2C9 (which inhibits both CYP2C9 and CYP2C19 catalytic activities) suppressed the progesterone 21-hydroxylation activities catalyzed by liver microsomes of humans and monkeys and that anti-CYP2C11 inhibited the progesterone 21-hydroxylation activities catalyzed by liver microsomes of male rats. CYP2C19 was also found to oxidize testosterone at 17-position to form androstenedione. Androstenedione formation catalyzed by liver microsomes of humans and monkeys and of male rats was suppressed by anti-CYP2C9 and anti-CYP2C11, respectively. These results suggest that CYP2C19 plays important roles in the oxidation of progesterone and testosterone in human liver microsomes, although the physiological significance of these metabolic pathways remains unclear. CYP2C9 may have some, but lesser extent than those by CYP2C19, of the catalytic roles for the metabolism of progesterone and testosterone by human liver microsomes.
Purification and characterization of a form of cytochrome P450 from bear liver microsomes
1995, Biochemical Pharmacology
A form of P450 [termed P450(b-1)] was purified from male bear liver microsomes. The specific content of the final P450(b-1) preparation was 11.26 nmol/mg protein, and recovery was 0.20% of the microsomal P450. The apparent molecular weight of P450(b-1) was 54,000. The absorption spectrum of P450(b-1) indicated that this protein was a low- and high-spin mixed type P450 in the oxidized form. The carbon monoxide complex of reduced P450(b-1) showed an absorption peak at 450.5 nm. The reconstituted system containing P450(b-1) catalyzed the metabolism of aminopyrine, benzo[a]pyrene, 7-ethoxycoumarin, imipramine and propranolol, of which P450(b-1) most strongly catalyzed aminopyrine N-demethylation and imipramine N-demethylation. The N-terminal amino acid sequence of P450(b-1) was highly homologous to that of P450-D1 from liver microsomes of male beagle dogs. P450(b-1) showed similarities in spectral properties, N-terminal amino acid sequence, and catalytic activities to rat P450 2C11. P450(b-1) was immunochemically cross-reactive with anti-P450 2C11 antibody and very weakly cross-reactive with anti-P450 2E1 antibody, but did not react with anti P450 1A1 or 2B1 antibodies. On the basis of these results, we suggest that P450(b-1) belongs to the P450 2C subfamily.
A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes purification, cDNA cloning, and enzyme characterization
1995, Archives of Biochemistry and Biophysics
A new form of cytochrome P450 (P450 DUT2) was purified from untreated male dog liver microsomes. The final preparation (a specific content of 19.1 nmol P450/mg protein) showed a single band with an apparent monomeric molecular weight of 50,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, but was further separated into two apoproteins (P450 DUT2_a and P450 DUT2_b) by reverse-phase HPLC. Both proteins had identical NH₂-terminal amino acid sequences, but the first three amino acids of P450 DUT2_b were truncated in P450 DUT2_a. Purified P450 DUT2 showed 5 to 18 times higher catalytic activities than did hepatic microsomes toward desipramine, metoprolol, and dextromethorphan. These activities in dog liver microsomes were strongly inhibited by anti-P450 DUT2-IgG. A 1.7-kilobase pair cDNA (cDUT2) encoding a male dog liver P450 of 500 amino acid residues (molecular weight 56,400) was isolated and sequenced. The first 35 NH₂-terminal amino acid sequence of P450 DUT2_b coincided with the deduced amino acid sequence of cDUT2 at 2-36. The deduced total amino acid sequence of cDUT2 shared high similarity with the reported 2D forms (with 2D6, 74.6%; 2D14, 75.4%; 2D1, 65.4%; and 2D9, 63.6%). Moreover, the expressed P450 DUTS in COS-7 cells had catalytic activities similar to those of purified P450 DUT2. Therefore, this paper is the first report about dog CYP2D. Furthermore, Northern and Western blot analyses indicated that the expressed levels of mRNA and protein were almost equal between male and female dogs. Western blot analysis suggested that P450 DUT2 is a constitutive and major (approximately 20% of the total P450) form, indicating that the 2D subfamily P450 in dog Liver is quite unique from CYP2D members of other species.
Monoclonal antibodies of differentiating specificities as probes of cytochrome P450h (2C11)
1993, Archives of Biochemistry and Biophysics
A panel of 30 monoclonal antibodies against rat hepatic microsomal cytochrome P450h (2C11) has been produced, purified, and characterized. A broad range of reactivities was observed when 13 purified rat cytochrome P450 isozymes were tested for epitope relatedness in a noncompetitive enzyme-linked immunosorbent assay or on immunoblots. Several antibodies were antigen-specific, others reacted with additional members of the 2C subfamily, and other monoclonal antibodies recognized cytochromes P450 from the 2E, 2B, 2A, and 1A subfamilies. Cytochromes P450p (3A1) and P4501 (3A2) did not react with any of the antibodies. A minimum of seven spatially distinct epitopes on cytochrome P450h were defined by the panel of antibodies. Immunoblot analysis of rat microsomes illustrated the male specificity of cytochrome P450h expression which extended to extrahepatic tissues including kidney and lung. A survey of various species by immunoblot analysis with several antibodies revealed little if any epitope relatedness among microsomal proteins from rats, mice, rabbits, hamsters, squirrel monkeys, guinea pigs, or humans. All of the antibodies were screened as potential inhibitors of cytochrome P450h-mediated testosterone hydroxylation in a reconstituted system. Although most of the antibodies were noninhibitory, greater than 70% inhibition of 2a-and 16a-hydroxylation of testosterone was observed with selected antibodies. These inhibitory antibodies gave similar results when benzphetamine-demethylation was evaluated in the reconstituted system. The inhibitory antibodies were then used to assess the role of cytochrome P450h in microsomal benzphetnmine N-demethylation, since this isozyme exhibits high catalytic activity for this substrate. Only 20-25% inhibition of benzphetamine metabolism was attained in microsomal preparations from adult male rats, and the antibodies did not influence the microsomal catalytic activity of immature males or females or adult females. Thus, despite the high level of expression of cytochrome P450h in microsomes from adult male rats and the high catalytic activity of the purified protein for benzphetamine, this isozyme contributes only a small portion of the metabolism of this substrate in microsomes.
Toxicological sifnificance of dog liver cytochrome P-450: examination with the enzyme expressed in Saccharomycees cerevisiae using recombinant expression plasmid
1992, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
A complementary DNA (cDNA) coding for a form of beagle dog cytochrome P-450 (Dahl), which is the orthologue to the CYP1A1 cDNA of rat, mouse and human, was inserted between the alcohol dehydrogenase (ADH) promoter and terminator regions of the yeast expression vector pAAH5. On introduction of the resulting recombinant plasmid pDC-1, Saccharomyces cerevisiae strain AH22 cells synthesized up to 1.5 × 10⁵ molecules per cell of cytochrome P-450 protein (P-450(Dah1)). The carbon monoxide-bound reduced form of P-450(Dah1) showed an absorption peak at 447 nm and specific content of P-450(Dah1) was about 0.1 nmole P-450 per mg of microsomal protein. P-450(Dah1) cross-reacted with antibodies to rat P-448-H (CYP1A2) and dog P-450-D2 (CYP1A2). P-450(Dah1) activated 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) most efficiently in the umu test and exhibited a high activity of aryl hydrocarbon hydroxylase toward benzo[a]pyrene.
Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics
2013, Drug Metabolism Reviews

View all citing articles on Scopus

View full text

Interspecies homology of liver microsomal cytochrome P-450: A form of dog cytochrome P-450 (P-450-D1) crossreactive with antibodies to rat P-450-male

Abstract

Archs Biochem. Biophys.

J. biol. Chem.

Archs Biochem. Biophys.

J. biol. Chem.

Analyt. Biochem.

J. biol. Chem.

Biochim. biophys. Acta

J. biol. Chem.

J. biol. Chem.

Analyt. Biochem.

Analyt. Biochem.

J. biol. Chem.

Pharmac. Rev.

Xenobiotica